RecruitingNot ApplicableNCT05842603

I Can Move With Purpose Now! A Pilot Lifestyle Intervention Study in Myeloproliferative Neoplasm Patients

Sponsor

Massachusetts General Hospital

Enrollment

30 participants

Start Date

Mar 1, 2024

Study Type

INTERVENTIONAL

Conditions

Leukemia Myeloproliferative Disorders

Summary

The goal of this study is to see if patients with myeloproliferative disorders are able to successfully complete the Cardiac Lifestyle Program(CLP). The goal of the CLP is to teach patients how to become more active and eat healthier foods. The name of the intervention used in this research study is: Cardiac Lifestyle Program (a 12-week, tailored nutrition and physical activity program)

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This pilot study tests a lifestyle program combining exercise and health education for people with myeloproliferative neoplasms (MPNs) — a group of blood cancers where the bone marrow produces too many blood cells. The program focuses on reducing cardiovascular risk and improving quality of life. **You may be eligible if...** - You are 18 or older - You have been diagnosed with an MPN (including essential thrombocythemia, polycythemia vera, myelofibrosis, or related conditions) - If you have myelofibrosis, your disease is classified as low or intermediate-1 risk - You have at least one cardiovascular risk factor (such as obesity, high blood pressure, high cholesterol, or diabetes) - You are in good enough health to exercise (ECOG performance status 0 to 1) **You may NOT be eligible if...** - You have high or intermediate-2 risk myelofibrosis - You are unable to safely participate in physical activity - You have had a cardiovascular event (heart attack or stroke) in the past 6 months Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALCardiac Lifestyle Program

12-week, tailored nutrition and physical activity program comprised of virtual and in-person classes.

Locations(3)

Brigham and Women's Hospital

Boston, Massachusetts, United States

Dana-Farber Cancer Institute

Boston, Massachusetts, United States

Massachusetts General Hospital Cancer Center

Boston, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05842603

Related Trials

Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy

NCT052379863 locations

Time-limited Triplet Combination of Pirtobrutinib, Venetoclax, and Obinutuzumab for Patients With Treatment-naïve Chronic Lymphocytic Leukemia (CLL) or Richter Transformation (RT)

NCT055363491 location

Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML

NCT06578247288 locations

Next Generation Sequencing (NGS) in Familial Acute Myeloid Leukemia and Myelodisplastic Syndromes

NCT030585881 location

A Safety and Efficacy Study of CD-19 t-haNK in Patients With B-cell Acute Lymphoblastic Leukemia

NCT075567572 locations